Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02405754 · ClinicalTrials.gov registry record

Clinical Utility of an Age, Sex, and Gene Expression Score (ASGES or Corus CAD) in African American Patients.

A clinical trial, sponsored by CardioDx.

Completed
Registry status
667
Enrollment target

NCT02405754: Completed study, sponsored by CardioDx.

NCT02405754 is a clinical trial that has completed, run by CardioDx. The registered enrollment target is 667 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02405754 has completed, sponsored by CardioDx.

COMPLETED
Registry status
667 participants
Enrollment target

Study Summary

This is a retrospective study, designed to be conducted at a single-center in the US. The study will conduct a one-time data abstraction from approximately 500 patient medical charts who received Age/Sex/Gene Expression score (ASGES) also knows as Corus CAD testing, by order of the Principal Investigator. Limited demographic data and patient data pertaining to cardiology referral or advanced diagnostic testing will be collected. All data will be collected anonymously.

Primary Outcome

Referral rate of patients receiving Age/Sex/Gene Expression Score (ASGES) or Corus CAD , expected follow-up up to 1 year

Interventions

  • DIAGNOSTIC_TEST Corus CAD (ASGES)

Trial Details

FieldValue
Enrollment Target 667 participants
Start Date 2014-02
Est. Completion 2014-08
CardioDx

11 total trials

What the finished NCT02405754 record still lists

NCT02405754 is an observational study that tracks outcomes without assigning an intervention. The registered 667 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Corus CAD (ASGES) is the first listed.

NCT02405754 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02405754 about?

NCT02405754 is a clinical study titled "Clinical Utility of an Age, Sex, and Gene Expression Score (ASGES or Corus CAD) in African American Patients.". This is a retrospective study, designed to be conducted at a single-center in the US. The study will conduct a one-time data abstraction from approximately 500 patient medical charts who received Age/Sex/Gene Expression score (ASGES) also knows as Corus CAD testing, by order of the Principal Investi...

What is the current status of trial NCT02405754?

This trial is currently completed. The enrollment target is 667 participants. The study started on 2014-02. Estimated completion is 2014-08.

What interventions are being tested in trial NCT02405754?

The interventions under investigation include: Corus CAD (ASGES) (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT02405754?

This trial is sponsored by CardioDx, which has 11 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04155034 · 668 participants · Phase 3

    S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer

  • NCT04179981 · 668 participants · NA

    Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)

  • NCT05006482 · 668 participants · Phase 3

    Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial

  • NCT06328647 · 666 participants · NA

    Quantra Point-of-Care Hemostasis Monitoring

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02405754, the US trial registry maintained by the National Library of Medicine. NCT02405754 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.